199265438+February, China tonghua dongbao group was established. During this period, several enterprises have been merged successively, especially Hengde Village 1992, Mill Town, Tonghua County, where the group is located, which is the first model of "combination of enterprises and agriculture" in China and has aroused strong repercussions throughout the country. Since the establishment of the Group 13, the rapid development of enterprise scale, the wide range of diversified project management, the numerous mergers of state-owned private enterprises, the pioneering of production equipment and technological processes, and the high level of research by scientific research teams have all been miracles of the development of domestic enterprises, and have been praised as "Dongbao Model" by people in the industry, creating the myth of the rapid and vigorous development of enterprises in China.
Dongbao Pharmaceutical attracts worldwide attention with its most advanced biopharmaceutical frontier technology. A large number of national new drugs and fist products such as "Zhennaoning", Dongbao Gantai tablets and Naoxuekang tablets have been developed one after another. In the field of biopharmaceuticals, the group invested hundreds of millions of yuan in scientific research, and successfully developed a high-tech preparation drug "Ganshulin" with independent intellectual property rights in China on 1998, which filled the domestic gap, making China the third country in the world to produce recombinant human insulin, and the second country to produce insulin glargine after the United States and Denmark. This achievement was awarded the National Top Ten Science and Technology Progress News Award by 587 academicians of China Academy of Engineering. The second phase expansion project of Dongbao gene recombinant human insulin, a key project supported by the state to revitalize the old industrial base in Northeast China with a total investment of 350 million yuan, is in full swing to introduce and install foreign advanced equipment, which will reach 3,000 kg in the next two years to meet the growing domestic and international market demand. Dongbao Group has become one of the production bases of human insulin with considerable scale and advanced technology in the world.
Dongbao Group adheres to Scientific Outlook on Development and actively builds a harmonious enterprise. 1994, the group established the first nature reserve built by enterprises in China in Babaogou. 1995 has invested more than 6 million yuan to build a 507-meter-long dam and retaining dam; At the beginning of 2003, the group passed the national ISO 1400 1 environmental management system certification; The Group has become an eco-modern enterprise with beautiful mountains and clear waters and sky blue, and achieved mutual benefit and win-win results in economic and ecological benefits.